136 related articles for article (PubMed ID: 12214584)
21. Edema of the eyelids and sclera after rituximab infusion for orbital MALT lymphoma.
Oribe N; Tanimoto TE; Shimoda K; Hikiji W; Mitsugi K; Takase K; Henzan H; Numata A; Miyamoto T; Fukuda T; Nagafuji K; Harada M
Haematologica; 2004 Jun; 89(6 Suppl):EIM14. PubMed ID: 15194556
[No Abstract] [Full Text] [Related]
22. Isoniazid-induced serum sickness: report of case.
Simelaro J; Dale J; Guest D
J Am Osteopath Assoc; 1981 Jan; 80(5):348-9. PubMed ID: 7462048
[No Abstract] [Full Text] [Related]
23. Images in emergency medicine. Serum sickness-like reaction to amoxicillin.
Lin B; Strehlow M
Ann Emerg Med; 2007 Sep; 50(3):350, 359. PubMed ID: 17709052
[No Abstract] [Full Text] [Related]
24. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
[TBL] [Abstract][Full Text] [Related]
25. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature.
Dhand S; Bahrain H
Cancer Invest; 2008 Nov; 26(9):913-5. PubMed ID: 19034773
[TBL] [Abstract][Full Text] [Related]
26. Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies.
Killestein J; Jasperse B; Liedorp M; Seewann A; Polman Ch
Mult Scler; 2009 Apr; 15(4):525-6. PubMed ID: 19324985
[No Abstract] [Full Text] [Related]
27. Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression.
Snow MH; Cannella AC; Stevens RB; Mikuls TR
Arthritis Rheum; 2009 Sep; 61(9):1271-4. PubMed ID: 19714613
[No Abstract] [Full Text] [Related]
28. Rituximab monotherapy as interim therapy in precursor B-ALL adults during periods of hepatic toxicity: report of two cases.
Koren-Michowitz M; Rahimi-Levene N; Volcheck Y; Hardan I; Kornberg A
Am J Hematol; 2006 Dec; 81(12):979-80. PubMed ID: 17019690
[TBL] [Abstract][Full Text] [Related]
29. Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma.
Arai Y; Tadokoro J; Mitani K
Am J Hematol; 2005 Apr; 78(4):317-8. PubMed ID: 15795913
[No Abstract] [Full Text] [Related]
30. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma.
Biehn SE; Kirk D; Rivera MP; Martinez AE; Khandani AH; Orlowski RZ
Hematol Oncol; 2006 Dec; 24(4):234-7. PubMed ID: 16948177
[TBL] [Abstract][Full Text] [Related]
31. Rituximab: new indication. Lymphoma maintenance therapy: inadequate follow-up.
Prescrire Int; 2007 Oct; 16(91):189. PubMed ID: 17926825
[TBL] [Abstract][Full Text] [Related]
32. Rituximab-induced serum sickness in multiple sclerosis patients.
Wolf AB; Ryerson LZ; Pandey K; McGettigan BM; Vollmer T; Corboy JR; Alvarez E
Mult Scler Relat Disord; 2019 Nov; 36():101402. PubMed ID: 31542710
[TBL] [Abstract][Full Text] [Related]
33. Tolerability and safety of rituximab (MabThera).
Kimby E
Cancer Treat Rev; 2005 Oct; 31(6):456-73. PubMed ID: 16054760
[TBL] [Abstract][Full Text] [Related]
34. Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.
Ozgönenel B; Moonka D; Savaşan S
Am J Hematol; 2006 Apr; 81(4):302. PubMed ID: 16550511
[No Abstract] [Full Text] [Related]
35. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
Tobinai K
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
[TBL] [Abstract][Full Text] [Related]
36. Case report of rituximab-induced thrombocytopenia.
Shah C; Grethlein SJ
Am J Hematol; 2004 Apr; 75(4):263. PubMed ID: 15054827
[No Abstract] [Full Text] [Related]
37. Avoiding a Rash Diagnosis: Rituximab-Induced Serum Sickness.
Mantilla B; Liew JW
J Clin Rheumatol; 2021 Jun; 27(4):e155-e159. PubMed ID: 30363002
[No Abstract] [Full Text] [Related]
38. Serum sickness in a child treated with cefaclor.
Johnson T; Stern C; Feild C
J Ark Med Soc; 1983 Jul; 80(2):110. PubMed ID: 6225768
[No Abstract] [Full Text] [Related]
39. Serum sickness-like reactions in patients receiving intravenous infliximab.
Gamarra RM; McGraw SD; Drelichman VS; Maas LC
J Emerg Med; 2006 Jan; 30(1):41-4. PubMed ID: 16434333
[TBL] [Abstract][Full Text] [Related]
40. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment.
Wang J; Wiley JM; Luddy R; Greenberg J; Feuerstein MA; Bussel JB
J Pediatr; 2005 Feb; 146(2):217-21. PubMed ID: 15689912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
